Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

MiNK Therapeutics, Inc. (INKT) vs XBiotech Inc. (XBIT)

MiNK Therapeutics, Inc. and XBiotech Inc. are both Biotechnology companies. MiNK Therapeutics, Inc. and XBiotech Inc. are of similar size ($65.9M and $62.8M). Across the 8 metrics below, MiNK Therapeutics, Inc. leads on 6 and XBiotech Inc. on 2.

Valuation

Metric INKT XBIT Biotechnology median
P/E n/m n/m 7.88
P/S n/m 16.50 11.47
P/B n/m 0.52 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.71 0.74
EV/Sales n/m (8.26) 10.73
Earnings yield (19.70%) (68.20%) (28.84%)
Free cash flow yield (11.28%) (61.95%) (23.03%)

Profitability

Metric INKT XBIT Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 57.94% (29.94%) (57.72%)
Return on assets (187.78%) (28.90%) (49.22%)
Return on invested capital 0.00% (159.18%) 0.00%

Growth

Metric INKT XBIT Biotechnology median
Revenue growth (TTM) — (78.20%) 5.64%
EPS growth (last fiscal year) (2.45%) (18.25%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INKT XBIT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.23 33.15 4.73
Net debt to EBITDA 1.07 2.33 0.96

Dividend

Metric INKT XBIT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric INKT XBIT Biotechnology median
Market cap 62.77m 65.85m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack